InvestorsHub Logo
Followers 5
Posts 204
Boards Moderated 0
Alias Born 11/13/2014

Re: lizzy241 post# 357360

Wednesday, 10/20/2021 10:23:21 AM

Wednesday, October 20, 2021 10:23:21 AM

Post# of 427716
Dr. Reddy’s Icosapent Ethyl Capsules, 1 gram is approved for the following indication: as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (≥ 500 mg/dL) hypertriglyceridemia.

Please note that Dr. Reddy’s Icosapent Ethyl Capsules is not approved for the following indication: as an adjunct to maximally tolerated statin therapy to reduce the risk of myocardial infarction, stroke, coronary revascularization, and unstable angina requiring hospitalization in adult patients with elevated triglyceride (TG) levels (≥ 150 mg/dL) and established cardiovascular disease or diabetes mellitus and two or more additional risk factors for cardiovascular disease.

Limitations of Use: The effect of Icosapent Ethyl Capsules on the risk for pancreatitis in patients with severe hypertriglyceridemia has not been determined.


https://www.pharmacytimes.com/view/dr-reddy-s-laboratories-announces-launch-of-icosapent-ethyl-capsules

https://www.drreddys.com/pi/icosapent-ethyl-1g-pi.pdf

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News